This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: The Hong Kong Polytechnic University. Active years: 2013-2016.
Company Filing History:
Years Active: 2013-2016
Title: Innovations of Chung-hin Chui in Cancer Treatment
Introduction
Chung-hin Chui is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of cancer treatment through his innovative research and development of new compounds. With a total of two patents to his name, Chui is recognized for his dedication to advancing medical science.
Latest Patents
Chui's latest patents include a method of making and administering quinoline derivatives as anti-cancer agents. This invention relates to the preparation of quinoline derivative compounds and their application in treating both solid and non-solid tumors, particularly liver cancer. Another significant patent is for water-soluble polymer-based cantharimides, which are potentially selective anti-tumor agents. This cantharimide compound features a complex backbone structure that allows for various chemical modifications, enhancing its therapeutic potential.
Career Highlights
Chung-hin Chui is affiliated with The Hong Kong Polytechnic University, where he conducts his research. His work focuses on developing innovative solutions for cancer treatment, showcasing his commitment to improving patient outcomes through scientific advancements.
Collaborations
Chui collaborates with esteemed colleagues, including Johnny Cheuk-on Tang and Albert Sun-chi Chan. These partnerships enhance the research efforts and contribute to the development of effective cancer therapies.
Conclusion
Chung-hin Chui's contributions to cancer treatment through his innovative patents highlight his role as a leading inventor in the field. His work continues to inspire advancements in medical research and offers hope for improved cancer therapies.